New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2014
07:06 EDTMDCOThe Medicines Co. downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse downgraded The Medicines Co. following the surprisingly negative cangrelor FDA panel. The firm said the setback removes and important value driver and now sees limited outperformance for shares. Price target lowered to $35 from $45.
News For MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 18, 2015
08:54 EDTMDCOThe Medicines Co. anticipates potential partnership talks
Subscribe for More Information
08:52 EDTMDCOThe Medicines Co. anticipates four U.S. FDA approvals in 2015
08:41 EDTMDCOThe Medicines Co. says not giving financial guidance due to Hospira suit
Subscribe for More Information
07:01 EDTMDCOThe Medicines Co. reports Q4 adjusted EPS 20c, consensus (82c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use